Privia Health Group, Inc. $PRVA Shares Bought by MQS Management LLC

MQS Management LLC raised its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 8.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 10,167 shares of the company’s stock after acquiring an additional 795 shares during the quarter. MQS Management LLC’s holdings in Privia Health Group were worth $234,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. CWM LLC grew its position in Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 604 shares in the last quarter. Bessemer Group Inc. grew its position in Privia Health Group by 2,393.4% in the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock valued at $51,000 after acquiring an additional 2,178 shares in the last quarter. Russell Investments Group Ltd. grew its position in Privia Health Group by 2,852.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after acquiring an additional 2,567 shares in the last quarter. GAMMA Investing LLC grew its position in Privia Health Group by 113.1% in the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock valued at $64,000 after acquiring an additional 1,521 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its position in Privia Health Group by 2,115.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock valued at $75,000 after acquiring an additional 3,173 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently commented on PRVA. JMP Securities boosted their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, August 29th. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. Piper Sandler cut their target price on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. Stephens restated an “overweight” rating and set a $32.00 target price on shares of Privia Health Group in a research note on Wednesday, September 24th. Finally, Citigroup restated an “outperform” rating on shares of Privia Health Group in a research note on Friday, August 29th. Eleven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $28.91.

Privia Health Group Stock Down 1.0%

Shares of PRVA opened at $25.73 on Tuesday. The stock has a 50 day moving average price of $23.60 and a 200 day moving average price of $22.70. The company has a market capitalization of $3.16 billion, a price-to-earnings ratio of 233.93, a price-to-earnings-growth ratio of 3.55 and a beta of 0.83. Privia Health Group, Inc. has a 52-week low of $17.45 and a 52-week high of $26.49.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. On average, equities analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.